China News
-
How to get your drug registered in China?
China | Regulatory | By BioSpectrum Bureau | 0 Comment | 25 Sep, 2012
The domain of biosciences in the Asia Pacific (APAC) region offers several opportunities for companies that are looking ...Read more
-
China houses 25 percent of diabetics worldwide
China | News | By BioSpectrum Bureau | 0 Comment | 12 Sep, 2014
Singapore: Researchers from the Chinese University of Hong Kong have come up with a new study that has made some stark c...Read more
-
WuXi Pharma ventures into Israel
China | News | By BioSpectrum Bureau | 0 Comment | 04 Nov, 2014
Singapore: China headquarterd WuXi PharmaTech has expanded its presence in Israel to provide integrated R&D services...Read more
-
China | News | By BioSpectrum Bureau | 0 Comment | 26 Sep, 2014
Singapore: Royal Bank of Scotland chief, Mr Philip Hampton, is getting on board of drug giant GlaxoSmithKline as non-exe...Read more
-
TNI BioTech, Qianjiang Pharma join hands
China | News | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2014
Singapore: US-based TNI BioTech, a biotechnology company focused on autoimmune diseases in emerging nations, has partner...Read more
-
DS Healthcare opens first store in China
China | News | By BioSpectrum Bureau | 0 Comment | 21 Jul, 2014
Singapore: Leading personal care products and specialty pharmaceuticals developer, DS Healthcare Group has opened its fi...Read more
-
GSK slashes its growth forecasts
China | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2014
Singapore: GSK lacerated its growth forecasts as its CEO, Sir Andrew Witty expressed concern over falling sales. Sir Wit...Read more
-
WuXi buys NextCode Health for $65M
China | News | By BioSpectrum Bureau | 0 Comment | 12 Jan, 2015
Singapore: China based WuXi PharmaTech has acquired NextCODE Health, a genomic analysis and bioinformatics company with ...Read more
-
CFDA approves peripheral T-cell lymphoma drug
China | Regulatory | By BioSpectrum Bureau | 6 Comment | 12 Jan, 2015
‎Singapore: Chinese Food and Drug Administration (CFDA) has approved Chidamide (Epidaza), an orally administrated ...Read more
-
Hong Kong firm develops anti-pruritus nanopatch
China | News | By BioSpectrum Bureau | 0 Comment | 12 Jan, 2015
Singapore: Hong Kong based drug company, Comprehensive Drug Enterprises, has developed and registered high-performance a...Read more
-
China | News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2015
Singapore: New cases of H7N9 being reported from China's Guangdong province has raised the number of people infected by ...Read more
-
GSK fined $490m in Chinese bribery scandal
China | News | By BioSpectrum Bureau | 0 Comment | 19 Sep, 2014
Singapore: Concluding the long drawn probe into British drug maker GlaxoSmithKline's operations in China, the country ha...Read more
-
Telstar adds yet another product to its portfolio
China | News | By BioSpectrum Bureau | 0 Comment | 02 Jan, 2015
Singapore: Telstar, a leading service provider, recently announced that its subsidiary will manufacture loading and unlo...Read more
-
3SBio, DiNonA to develop leukemia drug
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2016
Singapore: China-based biotech 3SBio declared that it has signed an exclusive license with DiNonA for the development, p...Read more
-
China healthcare IT market to reach $3.97 bn by 2020
China | News | By BioSpectrum Bureau | 0 Comment | 02 Dec, 2014
Singapore: China healthcare IT market earned revenues of $1.24 billion in 2013 and is estimated to reach $3.97 billion b...Read more
-
Exit from China for foreign pharma executives?
China | News | By BioSpectrum Bureau | 0 Comment | 16 Jun, 2014
Singapore: Ahead of the charges levelled out against British drug maker GlaxoSmithKline in China, other foreign executiv...Read more
-
Dishman might sell China plant to clear debts
China | News | By BioSpectrum Bureau | 0 Comment | 13 Jan, 2014
Singapore: India's Ahmedabad based contract research and manufacturing services (CRAMS) company Dishman Pharmaceuticals ...Read more
-
What's the stem cell regulatory scenario like in APAC?
China | Analysis | By Piyusha Chatterjee | 4 Comment | 31 Jan, 2013
The pioneering work of Nobel Laureates Sir John Gurdon and Dr Shinya Yamanaka on reprogramming adult stem cells has open...Read more
